The present position regarding the treatment of tuberculous meningitis in childhood is that parents can be offered a go per cent. chance of complete recovery. This transformation is due to the introduction of streptomycin and isonicotinic acid hydrazide. Whereas streptomycin first changed a uniformly fatal disease to one with a mortality of 70 per cent., isoniazid has made it possible to press home the advantage so that 95 per cent. of early cases recover. A long distressing illness has become short. Treatment in the later stages can be continued at home. Tuberculous meningitis can now be considered in similar terms to pyogenic meningitis.
This progress has been illustrated by the experience of Professor Debre1 who recently reviewed groups of children treated by different routines.
I947-Short interrupted courses of streptomycin: 93 cases; 66 deaths; 29 
Isoniazid
Such is the importance of isoniazid that a review of some of the relevant facts is necessary. Bacterial resistance to isoniazid is rare. Noufflard and Raynaud (quoted by Debre3) found that only one out of 71 cultures of M. tuberculosis contained organisms resistant to isoniazid and that this culture was not resistant to streptomycin. In a larger series no isoniazid-resistant culture was found among 219 investigations whereas 4 out of 159 were resistant to streptomycin (Debre4). In a report on the treatment of tuberculosis by the Medical Research Council5 the development of isoniazid resistance was observed in patients with pulmonary tuberculosis. Sixty-two per cent. of patients excreted organisms resistant to isoniazid after three months' treatment. When streptomycin and isoniazid were combined the corresponding figure was i i per cent.
Isoniazid diffuses readily into all tissues, across the cell membrane and notably across the' bloodbrain barrier.' Fletcher6 showed that bacteriostatic levels of isoniazid could be achieved in the cerebrospinal fluid by an oral dose of IO Bachmann and Wechselberg'0 claimed a survival rate of 72 per cent. in cases treated with isoniazid alone though the rate was 84 per cent. in cases not given intrathecal isoniazid. In the same paper they report the survival of all the patients in a group of seven treated with streptomycin and isoniazid. Ricci et al.11 quote a survival rate of 76 per cent. using a dose of io to 15 mg. per kgm. and ColariziI2 achieved 8i per cent. using 20 to 30 mg. per kg. Both teams used intrathecal isoniazid but used no other antibotic. Ferreira and Ferreira13 treated I 2 cases with isoniazid alone. Five of these patients had had initial courses of streptomycin and PAS. All cases responded to this regime but were reported after only six months had elapsed at which time the majority were still receiving treatment.
Debre' also mentions reports by Ramos, Walter, Heilmeyer and others showing survival rates of 85 to go per cent. in small series of cases.
Heilmeyer used very large doses of isoniazid-up to i.o gm. daily.
It is not yet possible to pronounce that streptomycin is obsolete nor that isoniazid alone can be relied upon to eradicate the disease in all cases. Lorber's results quoted above are better than any so far reported for a series treated without streptomycin. Bachmann and Wechselberg10 report ioo per cent. success with seven patients given streptomycin and isoniazid but only three patients out of nine survived when given intrathecal but not intramuscular streptomycin with isoniazid.
Spies et al.14 obtained almost identical survival rates in two small groups comparing isoniazid alone with streptomycin plus isoniazid but followed the patients for only six months. Debre now recommends isoniazid combined with PAS for early cases without impairment of consciousness but has not yet reported any results of such a regime. It would seem reasonable to retain streptomycin for advanced cases and others with a poor prognosis.
Is Intrathecal Treatment Essential ?
With increased confidence following the introduction of isoniazid many paediatricians have sought to abandon intrathecal treatment. In a few reports improvement has been noted in seriously ill patients from the time intrathecal medication was stopped. Already many experienced workers have reduced the number of intrathecal injections given to their patients. Debre3 at first reduced the period of daily injections to one month. Later he advised that intrathecal administration was necessary only until the patient showed improvement; that is, an improvement in the level of consciousness. In some patients this was less than one week. Lorber2 reported a reduction in the number of injections from go to a minimum of 25. Daily injections are given for a week followed by three injections each week, the average number in this series being 32. It is in this series that a survival rate of 95 per cent. was achieved. Ginabredal5 quotes a survival rate of 82.6 per cent of 46 cases given intrathecal streptomycin for the first month of treatment whereas only 70 per cent. of 20 children survived when intrathecal treatment was omitted.
Pet6nyil6 recently reported a comparison of three series treated by different routines. Ninetyfour patients were treated with streptomycin only in large doses (up to 1.5 gm. daily). Of these 13 died (86.2 per cent. survival). Using streptomycin with isoniazid, 88 per cent. of 95 patients *survived when given daily medication and in a series of 31 patients 93 per cent. survived when treatment was given every second or third day. No child was given intrathecal treatment and it was stated in this report that 22 per cent. of the children were younger than two years and 6o per cent. were admitted ' in a paralytic state.' Bulkeley17 claimed a survival rate of 93.5 per cent. in 31 children who were treated with corticotrophin. Improvement was so encouraging that the majority of these cases had no intrathecal treatment but eight had had an initial course of intrathecal streptomycin. An earlier group given intrathecal treatment showed a go per cent. survival rate. 
